PRESS
profile

HCV New Drug Research
Keeping current on the potential arrival of new improved hepatitis C drugs. As once a hepatitis C patient myself (I successfully treated the virus with standard HCV therapy in 2000) I understand the difficult decisions and overwhelming fear that ensues after being diagnosed with this serious and life-changing disease. This blog serves as a starting point for information on the rapidly evolving number of new agents in development to treat hepatitis C
http://hepatitiscnewdrugs.blogspot.com/
Barcode
Valid 10 years unless revoked
First amendment rights: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the government for a redress of grievances.
Protease inhibitors improved sustained virologic response rate in HCV
65 views | Healthcare | Dec 12 2012 19:54
Monoclonal antibody GS-6624 well tolerated by patients with hepatic fibrosis in initial safety study
79 views | Healthcare | Dec 03 2012 16:32
Boceprevir and Telaprevir-Direct Anti-HCV Drugs Show Good Response in Routine Practice
28 views | Healthcare | Dec 03 2012 16:32
Hepatitis C-Lessons From The Liver Meeting
55 views | Healthcare | Nov 30 2012 15:41
Sofosbuvir (GS-7977) Hepatitis C drug shows promise in late-stage trial
281 views | Healthcare | Nov 30 2012 01:20
Hepatitis C Responds Better to Triple Antiviral Therapy
24 views | Healthcare | Nov 27 2012 10:20
Which patients should be prioritised for new hepatitis C treatments?
21 views | Healthcare | Nov 26 2012 19:52
Multiple study results indicate safety, efficacy of sofosbuvir (GS-7977) in HCV patients
92 views | Healthcare | Nov 22 2012 23:13
AASLD - BIT225 Hepatitis C Virus 48-week data
33 views | Healthcare | Nov 18 2012 17:01
Hepatitis C-Managing Adverse Effects and Complications in Completing Treatment
29 views | Healthcare | Nov 18 2012 17:00

SignUp

Login